✦ LIBER ✦

Treatment of ocular myoclonus with valproic acid

✍ Scribed by David Lefkowitz; Gary Harpold

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 231 KB
Volume: 17
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410170123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valproic acid treatment results in incre

Valproic acid treatment results in increased accumulation of prion proteins

✍ Gideon M. Shaked; Roni Engelstein; Inbal Avraham; Hannah Rosenmann; Ruth Gabizon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 1 views

Acute leukemia associated with valproic

Acute leukemia associated with valproic acid treatment: A novel mechanism for leukemogenesis?

✍ Thomas E. Coyle; Alicia K. Bair; Constance Stein; Neerja Vajpayee; Syed Mehdi; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

Treatment with valproic acid ameliorates

Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys

✍ MariaGiulia Torrioli; Silvia Vernacotola; Chiara Setini; Francesca Bevilacqua; D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Successful treatment of cherry red spot—

Successful treatment of cherry red spot—myoclonus syndrome with 5-hydroxytryptophan

✍ Dr. Generoso Gascon; Bradford Wallenberg; Abdul Khadair Daif; Pinar Ozand 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 1 views

Treatment of cerebrotendinous xanthomato

Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid

✍ Dr. Timothy A. Pedley; Ronald G. Emerson; Carolyn L. Warner; Lewis P. Rowland; G 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

Successful treatment of SAPHO syndrome w

Successful treatment of SAPHO syndrome with zoledronic acid

✍ Petros Kopterides; Dimitrios Pikazis; Christos Koufos 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract The SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is a chronic, relapsing, inflammatory condition with skin and osteoarticular manifestations. Its etiology remains unclear, and various treatment regimens with steroids and nonsteroidal antiinflammatory drugs fr